Peptic Ulcer Disease
📧 Sign up to get email alerts when something new happens for Peptic Ulcer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-02-26FDA Approved: IDKIT HP ONE — Supplemental Application (Meridian Bioscience Israel Ltd)
FDA Supplemental Application approval for IDKIT HP ONE, a 13C-urea citric acid breath test kit for detecting Helicobacter pylori infection.
-
FDA approval · 2010-01-31FDA Approved: RANITIDINE — Supplemental Application (Pharmaceutical Associates, Inc.)
The FDA approved a supplemental application for ranitidine filed by Pharmaceutical Associates, Inc., updating the drug's labeling. This acti…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)
A completed pediatric clinical trial investigates risk factors for gastric disease associated with Helicobacter pylori infection, including …
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment [NA]
A clinical trial update comparing high-dose versus standard-dose proton pump inhibitors for high-risk bleeding peptic ulcers after endoscopi…
-
CLINICAL_TRIALS trial_result · 2010-01-01Clinical Trial Update: Perforated Marginal Ulcer After Gastric Bypass
This document reports a completed clinical trial update on perforated marginal ulcers after gastric bypass surgery. It also references relat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-01-01Clinical Trial Update: Chronic Marginal Ulcers After Gastric Bypass
This clinical trial update indicates a completed study focused on marginal ulcers and other ulcer diseases associated with gastric bypass su…
-
CLINICAL_TRIALS trial_result · 2009-12-30Clinical Trial Update: Drop in Gastroscopy - Experience After 9 Months
A completed clinical trial update from the Norwegian Department of Health and Social Affairs reports gastroscopy outcomes after nine months …
-
CLINICAL_TRIALS trial_result · 2009-10-19Clinical Trial Update: Bioequivalence of Rebamipide in Korean [NA]
The study completed an evaluation of bioequivalence for Rebamipide in Korean subjects, addressing therapeutic equivalence and pharmacogeneti…
-
FDA approval · 2009-07-31FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for PREVACID SOLUTAB (lansoprazole) to add the Solutab dosage form to the approved product line. The…
-
CLINICAL_TRIALS research · 2009-07-08Clinical Trial Update: Helicobacter Pylori Empiric Treatment in Ulcer Bleeding [Phase 4]
Phase 4 clinical trial investigating empiric Helicobacter pylori treatment for ulcer bleeding; current status not disclosed.
-
FDA label_change · 2009-05-28FDA Approved: RANITIDINE — Supplemental Application (Pharmaceutical Associates, Inc.)
The FDA approved a supplemental application for ranitidine from Pharmaceutical Associates, Inc., indicating a labeling or related change to …
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination [Phase 1]
Phase 1 trial comparing a fixed-dose capsule of esomeprazole 40 mg with LDA 325 mg to the free combination; the study was completed. Sponsor…
-
FDA approval · 2009-02-27FDA Approved: CIMETIDINE 200 ACID REDUCER — Supplemental Application (Walgreen Company)
FDA approved a supplemental application to approve Walgreens' Cimetidine 200 Acid Reducer as a generic cimetidine product.
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion [Phase 4]
Phase 4 trial comparing famotidine with pantoprazole for preventing recurrent aspirin-induced peptic ulcers/erosions.
-
CLINICAL_TRIALS research · 2009-02-05Clinical Trial Update: The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy
A clinical trial update examining how Helicobacter pylori infection, bacterial density, and gastric histology change after antrectomy.
-
FDA approval · 2008-11-24FDA Approved: ACID CONTROLLER — Supplemental Application (H E B)
FDA approved a supplemental application for ACID CONTROLLER (famotidine) from H E B. The approval expands the product's labeling/indications…
-
FDA approval · 2008-09-12FDA Approved: SUCRALFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for sucralfate by Teva Pharmaceuticals USA, Inc., marking an approved modification to the generic pr…
-
FDA approval · 2008-06-30FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2008-03-20FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC, authorizing the continued marketing of a…
-
FDA approval · 2008-02-27FDA Approved: FAMOTIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for famotidine from Teva Pharmaceuticals USA, Inc., updating the approved generic product.
-
CLINICAL_TRIALS trial_result · 2008-01-11Clinical Trial Update: Lansoprazole Preventing Gastroduodenal Stress Ulcerations [Phase 4]
A Phase 4 study evaluating lansoprazole to prevent gastroduodenal stress ulcers in patients undergoing elective coronary artery bypass graft…
-
FDA approval · 2007-12-21FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for the combination product omeprazole and sodium bicarbonate from Oceanside Pharmaceuticals.
-
FDA approval · 2007-12-20FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth Pharmaceuticals LLC, a subsidiary …
-
FDA approval · 2007-08-31FDA Approved: RANITIDINE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved the original ANDA for ranitidine from Dr. Reddy's Laboratories Limited, enabling a generic ranitidine product to be marketed in…
-
FDA approval · 2007-08-20FDA Approved: CLARITHROMYCIN — Original Application (Chartwell RX, LLC.)
FDA approved a generic version of clarithromycin from Chartwell RX, LLC through an Original Abbreviated New Drug Application (ANDA).